P/B
8,8
West Pharmaceutical Services
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
$26.4B
Market Cap • 9/28/2026
1923
(103 years)
Founded
1973
(53 years ago)
IPO
NYSE
Listing Exchange
United States
Country
S&P500 Participant
Index Composite • 2026
Valuation
P/S
7,9
P/EBITDA
30,7
P/OCF
39,9
P/FCF
60,5
P/E
48,1
BVPS
41,4
EPS
7,8
Market Cap
Market Cap
26,4B
EV
26,3B
EV/Revenue
7,9
EV/EBITDA
30,5
EV/EBIT
38,7
Payout
Dividend Per Share
0,9
Dividend Yield
0,2%
Buyback Yield
1,6%
Total Yield
1,9%
Dividend Yield 5Y
0,3%
Payout
10,8%
Retained Earnings
4,6B
Profitability
Gross Margin
36,8%
EBITDA Margin
25,9%
EBIT Margin
20,5%
Net Margin
17%
D&A/EBITDA
0%
R&D/Revenue
2,2%
Capex/Revenue
6,8%
Capex/D&A
124,2%
Capex/OCF
34%
SBC/OCF
4,9%
% PPE
43,9%
% Goodwill
2,7%
ROE
19,1%
ROIC
18,3%
Growth
CAGR Revenue 5Y
5,7%
CAGR Op. Income 5Y
2,5%
CAGR Net Income 5Y
1,7%
CAGR EPS 5Y
2,7%
CAGR OCF 5Y
5,8%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
2,8
Quick Ratio
1,8
Interest Coverage
15120%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!